Zobrazeno 1 - 10
of 1 305
pro vyhledávání: '"Dallob A"'
Autor:
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, Andy Liaw, Matt Wiener, Cloud P Paweletz, Jeffrey L Seeburger, Jenny Li, Fanyu Meng, Ekaterina G Deyanova, Matthew T Mazur, Robert E Settlage, Xuemei Zhao, Katie Southwick, Yi Du, Dan Holder, Jeffrey R Sachs, Omar F Laterza, Aimee Dallob, Derek L Chappell, Karen Snyder, Vijay Modur, Elizabeth King, Catharine Joachim, Andrey Y Bondarenko, Mark Shearman, Keith A Soper, A David Smith, William Z Potter, Ken S Koblan, Alan B Sachs, Nathan A Yates
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135365 (2015)
Disease modifying treatments for Alzheimer's disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modificati
Externí odkaz:
https://doaj.org/article/9acb46913f794a2a8b1b2a7a679cc6a4
Autor:
Dallob, Aimee1 (AUTHOR), Luo, Wen-Lin1 (AUTHOR), Luk, Julie Mabalot1 (AUTHOR), Ratcliffe, Lisa1 (AUTHOR), Johnson-Levonas, Amy O.1 (AUTHOR), Schwartz, Jules I.1 (AUTHOR), Dishy, Victor2 (AUTHOR), Kraft, Walter K.3 (AUTHOR), De Hoon, Jan N.4 (AUTHOR), Van Hecken, Anne4 (AUTHOR), De Lepeleire, Inge5 (AUTHOR), Radziszewski, Waldemar1 (AUTHOR), Wagner, John A.1 (AUTHOR), Lai, Eseng1 (AUTHOR) eseng_lai@merck.com
Publikováno v:
Platelets. Nov2011, Vol. 22 Issue 7, p495-503. 9p. 5 Charts, 4 Graphs.
Autor:
Daniel J. Holder, Jeffrey L. Seeburger, C Joachim, Mary J. Savage, A. David Smith, Marc Combrinck, Vijay Modur, Karen Snyder, William Z. Potter, Michael Tanen, Derek L Chappell, Adam J. Simon, Omar F Laterza, Mary Flynn, Gordon K. Wilcock, Aimee Dallob
Publikováno v:
Journal of Alzheimer's Disease. 44:525-539
Cerebrospinal fluid (CSF) amyloid-β (Aβ) and tau have been studied as markers of Alzheimer's disease (AD). Combined Aβ42 and t-tau distinguishes AD from healthy controls with a sensitivity and specificity (sens/spec) near 89% across studies. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11086d3820f96774e32cc9a2d0e48c1
https://doi.org/10.3233/jad-141725
https://doi.org/10.3233/jad-141725
Autor:
Wight, Nicholas J. *, Gottesdiener, Keith, Garlick, Nigel M. *, Atherton, Clare T. *, Novak, Sue *, Gertz, Barry J., Calder, Nicole A., Cote, J., Wong, P., Dallob, Amy, Hawkey, Chris J. *
Publikováno v:
In Gastroenterology March 2001 120(4):867-873
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
Autor:
Drake, Lynn, Hordinsky, Maria, Fiedler, Virginia, Swinehart, James, Unger, Walter P., Cotterill, Paul C., Thiboutot, Diane M., Lowe, Nicholas, Jacobson, Coleman, Whiting, David, Stieglitz, Sam, Kraus, Stephen J., Griffin, Edmond I., Weiss, Darryl, Carrington, Patrick, Gencheff, Christopher, Cole, Gary W., Pariser, David M., Epstein, Edwin S., Tanaka, Wesley, Dallob, Aimée, Vandormael, Kristel, Geissler, Lori, Waldsteicher, Joanne
Publikováno v:
In Journal of the American Academy of Dermatology 1999 41(4):550-554
Autor:
Lisa Ratcliffe, Amy O. Johnson-Levonas, Wen-Lin Luo, Jules I. Schwartz, Jan de Hoon, Victor Dishy, Eseng Lai, Julie Mabalot Luk, John A. Wagner, Anne Van Hecken, Waldemar Radziszewski, Walter K. Kraft, Aimee Dallob, Inge De Lepeleire
Publikováno v:
Platelets. 22:495-503
Laropiprant (LRPT) is being developed in combination with Merck's extended-release niacin (ERN) formulation for the treatment of dyslipidemia. LRPT, an antagonist of the prostaglandin PGD2 receptor DP1, reduces flushing symptoms associated with ERN.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94880ac79925cac8bcf858465a5ad9ff
https://doi.org/10.3109/09537104.2011.565433
https://doi.org/10.3109/09537104.2011.565433
Autor:
Khairullina, Veronika1 (AUTHOR) khajrullinavr@uust.ru, Martynova, Yuliya1 (AUTHOR) ziminyus@uust.ru, Kanevsky, Matvey2 (AUTHOR) matvejkanev@mail.ru, Kanevskaya, Irina3 (AUTHOR) irinastrashilina@mail.ru, Zimin, Yurii1 (AUTHOR) leomaxcer@gmail.com, Maksimov, Leonid1 (AUTHOR)
Publikováno v:
Molecules. Dec2024, Vol. 29 Issue 23, p5540. 21p.
Autor:
de Freitas, Juliano Tiburcio1 (AUTHOR), Thakur, Varsha1 (AUTHOR), LaPorte, Kathryn M.2 (AUTHOR), Thakur, Vijay S.3 (AUTHOR), Flores, Brian1 (AUTHOR), Caicedo, Valentina1 (AUTHOR), Ajaegbu, Chioma G. E.1 (AUTHOR), Ingrasci, Giuseppe1 (AUTHOR), Lipman, Zoe M.1 (AUTHOR), Zhang, Keman4 (AUTHOR), Qiu, Hong4 (AUTHOR), Malek, Thomas R.2 (AUTHOR), Bedogni, Barbara1 (AUTHOR) bxb602@miami.edu
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 11/4/2024, Vol. 43 Issue 1, p1-14. 14p.
Autor:
Deborah Hilliard, Jules I. Schwartz, Derek L Chappell, Karen Snyder, Omar F Laterza, Patrick Larson, Jutta Miller, Mary Flynn, John A. Wagner, Jane Royalty, Aimee Dallob, Paul F. Cavanaugh
Publikováno v:
The Journal of Clinical Pharmacology. 48:745-754
We determined cyclo-oxygenase-1 and cyclo-oxygenase-2 inhibition in healthy middle-aged subjects (41-65 years) randomly assigned to four 7-day treatment sequences of etoricoxib 90 mg every day, celecoxib 200 mg twice a day, diclofenac 75 mg twice a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cb6ad034ecc121a79249ee904f1db4
https://doi.org/10.1177/0091270008317590
https://doi.org/10.1177/0091270008317590
Autor:
Xuemei Zhao, Jenny J. Li, Yi Du, Jeffrey L. Seeburger, C Joachim, Ronald C. Hendrickson, Andy Liaw, Andrey Bondarenko, Fanyu Meng, Derek L Chappell, Anita Y. H. Lee, Keith A. Soper, William Z. Potter, Mark S. Shearman, Matt Wiener, Nathan A. Yates, Cloud P. Paweletz, Katie Southwick, Qinghua Song, Aimee Dallob, Matthew T. Mazur, Vijay Modur, Robert E. Settlage, E. King, A. David Smith, Omar F Laterza, Ken S. Koblan, Ekaterina G. Deyanova, Karen Snyder, Dan Holder, Jeffrey R. Sachs, Alan B. Sachs
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135365 (2015)
PLoS ONE
PLoS ONE
Disease modifying treatments for Alzheimer's disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33846e24a255c34791aa098968a0c1a
http://europepmc.org/articles/PMC4535975?pdf=render
http://europepmc.org/articles/PMC4535975?pdf=render